Type 1 Diabetes—Reaping the Rewards of a Targeted Research Investment

Judith E. Fradkin; Julie A. Wallace; Beena Akolkar; Griffin P. Rodgers


Diabetes. 2016;65(2):307-313. 

In This Article


These advances, supported in part or in whole by the SDP, underscore how a targeted and sustained investment in type 1 diabetes research has enabled tremendous progress. As we celebrate the significant progress made to improve the lives of people with type 1 diabetes, we look forward to reaping additional rewards as the ongoing research investments come to fruition. This targeted investment has laid the groundwork for future advances toward a cure through β-cell replacement and ultimately toward prevention of the disease in those at risk.